SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) announced today that the company will present its systems for cancer therapy at the 2008 World Congress of Brachytherapy (the annual meeting of the American Brachytherapy Society or ABS) from May 4-6, 2008, in Boston, Massachusetts. The company’s objective at ABS is to leverage the growing clinical interest in the use of hyperthermia therapy with brachytherapy.
